When: RSI bullish divergence at oversold levels

Then: Partial re-engagement eligibility

When: Forward EPS reaffirmation at $6.00+ with Nutrition stabilization

Then: Partial re-engagement eligibility

Hold current size, trim into strength at 106-108, maintain stop at 81.98, wait through Q3 binary catalyst before adding

• RSI at 35 in confirmed downtrend without bullish divergence may grind into 20s, not immediately reverse
• Forward P/E 16.7 requires 55% EPS jump from 3.91 normalized baseline to 6.07 in hostile macro
• Death cross at beta 0.586 confirms medium-term trend change, not mean reversion setup
• 10-year at 2007 highs, 30-year at 2004 highs; Polymarket shows 41% odds of 3 Fed hikes, up 22.7 percentage points in one week
• 35-40% international revenue on ~16-18 billion creates 160-360 million dollar translation headwind, 120-250 million flow-through to earnings (2-4% of consensus)
• Q3 is binary catalyst with unknowns on Nutrition trajectory, FreeStyle Libre pricing, and 2027 CGM reimbursement environment
• 50 SMA at 106.67 and Bollinger midline at 106.05 provide resistance confluence for trimming
• $385 million formula settlement is ~7% of TTM net income with no rerating catalyst since already in consensus
• 82 retest would confirm May support failure = breakdown, not launchpad for 'generational' buying
• If 81.98 stop hits, downside opens to 75 or lower before real support
• Trim 10-15% into rallies at 106-108 to harvest liquidity and preserve dry powder

→ vs aggressive: Probability-weighted bull path to 110-115 is presented as 70% probable but actually closer to coin flip given 55% EPS expansion requirement in hostile macro with compressing multiples

→ vs aggressive: Death cross in defensive mega-cap is not a mean-reversion setup; beta measures volatility correlation not reversal tendency after trend breaks

→ vs aggressive: Rising yields create defensive rotation flow lasting weeks not quarters; long-end yield multi-decade highs compress equity present value across the board

→ vs aggressive: International translation drag is 160-360 million dollars not 100-200 basis points, representing 2-4% of earnings power

→ vs aggressive: Waiting through Q3 binary catalyst is discipline not weakness; unknowns on segment trajectory and guidance make 'bad news priced in' assumption dangerous

→ vs aggressive: Trimming at 106-108 is textbook distribution into resistance confluence, not 'leaving money on the table'

→ vs aggressive: 82 retest as buying opportunity misunderstands that failed second test of support = breakdown, not launchpad; loading up on confirmed structural failure would get a PM fired

→ vs aggressive: Risk-reward is symmetric at best and asymmetric bearish when accounting for path dependency; downside includes 75 or lower if stop hits

→ vs neutral: Waiting for 200 SMA reclaim, RSI turning up, and MACD histogram contracting is too late; confirmation signals come after stop is hit, not while maintaining position risk

HOLD with tiered contingency triggers; maintain current position sizing, stop at $81.98 with 1.5% portfolio risk cap

• Base case HOLD is correct; neither aggressive BUY nor defensive underweight is warranted at current uncertainty levels
• Bull path requires 55% EPS recovery from normalized $3.91 to $6.07, which is an earnings recovery layered on multiple expansion, not simple mean reversion
• Forward P/E of 16.7 versus five-year median of ~22 is meaningful but conditional on earnings story holding
• Death cross is bearish confirmation but not catastrophic; 42% recovery from $82 low shows stock is high-volatility rather than structurally broken
• Macro is net neutral: modest relative tailwind from defensive rotation, modest absolute headwind from long-end yield regime
• Revenue translation hit of $160-360M equals 2-4% of consensus earnings, not 100-200 basis points as conservative analyst overstated
• $385M formula settlement is a marginal tailwind as quantified resolution removes litigation overhang; conservative analyst wrong to dismiss it as already priced
• Q3 earnings is the decisive catalyst; thesis-driven exit if forward EPS walks down to $5.50 or below
• Time horizon is 3-6 months, not 3-4 weeks; wait for market to confirm before acting
• Tier 1 add: RSI below 30 with bullish divergence → add 5% with stop at $97; Tier 2: reclaim 200 SMA at $103.91 on volume with MACD contraction → add 5-10%; Tier 3: reclaim 50 SMA at $106.67 → trim original position to neutral, let new add ride with trailing stop

→ vs aggressive: Trim levels at $106-108 are not nonsensical; 50 SMA at $106.67 and Bollinger midline at $106.05 are real overhead resistance in a confirmed downtrend, and trimming 10-15% into those levels is capital preservation

→ vs aggressive: Adding on weakness toward $97.76 without confirmed price action is reckless; 'catching a falling knife with better marketing' rather than disciplined accumulation

→ vs aggressive: Calling $82 a 'generational defensive holding buying opportunity' is over-the-top language that gets investors loaded at wrong levels

→ vs conservative: 'Wait through it' is too passive a stance; there's a difference between not initiating new longs and being completely flat-footed into a print where the floor might be well-protected

→ vs conservative: 'If 82 gets hit, we exit' is too absolute; tapping 82 with a quick reversal that holds is different from a clean breakdown on volume

→ vs conservative: Settlement removing uncertainty is not already fully priced; assumes efficient market discounting of litigation tail risk in real time, which is questionable